ANVS vs TXT · $80.4M cap vs P/E 19, rev $7.52B
Annovis Bio Inc (ANVS) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
Annovis Bio Inc (ANVS) is a biotechnology company listed on US.
Textron Inc (TXT) is a aerospace & defense company listed on US.
Latest reported ANVS revenue for 2026-06-30 was $0. Net income was -$32.4M. ANVS currently screens at market cap $80.4M.
Latest reported TXT revenue for 2026-07-04 was $7.52B. Net income was $468.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
ANVS currently screens at market cap $80.4M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the ANVS and TXT stock pages for the full models.
Not investment advice.